High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support

International Journal of Cardiology

Volumn 153, Issue 1, 2011, Pages 59-63

  Iliodromitis, Konstantinos E ^a   Kahlert, Philipp ^a   Plicht, Bjorn ^a   Hoffmann, Andreas Claudius ^a   Eggebrecht, Holger ^a   Erbel, Raimund ^a   Konorza, Thomas F ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

30 day mortality; High risk PCI; Impella

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; AGED; ANEURYSM; AORTA BALLOON; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DISEASE SEVERITY; FALSE ANEURYSM; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT MEASUREMENT; HEMATOMA; HIGH RISK PATIENT; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; STENT THROMBOSIS; STROKE; SURGICAL RISK; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 81055144361     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.039     Document Type: Article

References (36)

1. R.O. Bonow, L.A. Smaha, and S.C. Smith Jr. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic Circulation 106 2002 1602 1605
2. T. Thom, N. Haase, and W. Rosamond Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 113 2006 e85 e151
3. R. Bigi, L. Cortigiani, and P. Colombo Prognostic and clinical correlates of angiographically diffuse non-obstructive coronary lesions Heart 89 2003 1009 1013
4. P.C. Keelan, J.M. Johnston, and T. Koru-Sengul Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions < or = 40%, 41% to 49%, and > or = 50% having percutaneous coronary revascularization Am J Cardiol 91 2003 1168 1172
5. M. Emond, M.B. Mock, and K.B. Davis Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry Circulation 90 1994 2645 2657
6. P.J. Scanlon, D.P. Faxon, and A.M. Audet ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions J Am Coll Cardiol 33 1999 1756 1824
7. M. Remmelink, K.D. Sjauw, and J.P. Henriques Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics Catheter Cardiovasc Interv 70 2007 532 537
8. M. Remmelink, K.D. Sjauw, and J.P. Henriques Effects of mechanical left ventricular unloading by Impella on left ventricular dynamics in high-risk and primary percutaneous coronary intervention patients Catheter Cardiovasc Interv 75 2 2010 Feb 1 187 194
9. M. Valgimigli, P. Steendijk, and G. Sianos Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention Catheter Cardiovasc Interv 65 2005 263 267
10. S.A. Nashef, F. Roques, and P. Michel European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
11. J. Nilsson, L. Algotsson, and P. Hoglund Comparison of 19 pre-operative risk stratification models in open-heart surgery Eur Heart J 27 2006 867 874
12. T.R. Ketch, S.J. Turner, and M.T. Sacrinty Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting Am Heart J 156 2008 234 240
13. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
14. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
15. E.G. Bovill, M.L. Terrin, and D.C. Stump Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Ann Intern Med 115 1991 256 265
16. B.J. Doyle, H.H. Ting, and M.R. Bell Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17, 901 patients treated at the Mayo Clinic from 1994 to 2005 JACC Cardiovasc Interv 1 2008 202 209
17. M.S. Sabatine, D.A. Morrow, and R.P. Giugliano Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
18. H. Omran, H. Schmidt, and M. Hackenbroch Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study Lancet 361 2003 1241 1246
19. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) Circulation 106 2002 1893 1900
20. J.J. Ferguson III, M. Cohen, and R.J. Freedman Jr The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry J Am Coll Cardiol 38 2001 1456 1462
21. M. Seyfarth, D. Sibbing, and I. Bauer A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction J Am Coll Cardiol 52 2008 1584 1588
22. H. Thiele, P. Sick, and E. Boudriot Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock Eur Heart J 26 2005 1276 1283
23. D. Burkhoff, H. Cohen, and C. Brunckhorst A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock Am Heart J 152 469 2006 e461 e468
24. K.H. Scholz, S. Ragab, and F. von zur Muhlen Complications of intra-aortic balloon counterpulsation. The role of catheter size and duration of support in a multivariate analysis of risk Eur Heart J 19 1998 458 465
25. R. Erbel, and G. Heusch Coronary microembolization-its role in acute coronary syndromes and interventions Herz 24 1999 558 575
26. R. Erbel, and G. Heusch Coronary microembolization J Am Coll Cardiol 36 2000 22 24
27. C. Cavallini, S. Savonitto, and R. Violini Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study Eur Heart J 26 2005 1494 1498
28. D.N. Feldman, R.M. Minutello, and G. Bergman Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes Am J Cardiol 104 2009 1210 1215
29. B. Meyns, J. Stolinski, and V. Leunens Left ventricular support by catheter-mounted axial flow pump reduces infarct size J Am Coll Cardiol 41 2003 1087 1095
30. P.C. Hebert, E. Yetisir, and C. Martin Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 29 2001 227 234
31. A. Haneya, A. Philipp, and C. Schmid Minimised versus conventional cardiopulmonary bypass: outcome of high-risk patients Eur J Cardiothorac Surg 36 2009 844 848
32. S.R. Dixon, J.P. Henriques, and L. Mauri A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience JACC Cardiovasc Interv 2 2009 91 96
33. J.L. Ferreiro, J.A. Gomez-Hospital, and A.R. Cequier Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention Int J Cardiol. 2009 Sep 2 [Electronic publication ahead of print]. Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention. (19732979[uid])
34. K.D. Sjauw, T. Konorza, and R. Erbel Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry J Am Coll Cardiol 54 2009 2430 2434
35. S. Mishra, W.W. Chu, and R. Torguson Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention Am J Cardiol 98 2006 608 612
36. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150